A recent study has revealed that beginning the intake of the generic drug called Metformin early in life could increase the success rate of the drug manifold in patients suffering from diabetes. Co-author Gregory A Nichols, an investigator with the Kaiser Permanente Center for Health Research, said: “We believe that starting the drug early preserves the body’s own ability to control blood sugar, which in turn prevents the long-term complications of diabetes like heart disease, kidney failure, and blindness”
The study, conducted by American researchers was published in the journal of American Diabetes Association. Scientists analyzed about 1800 diabetes patients for a period of five years. The study showed that the failure rate of Metformin in patients who had started taking the drug early in life was 21.4 per cent as compared to 21.9 percent in those who had not started intake three years until after the diagnosis of the disease.
“This is an important finding for the 30 million people world-wide who are diagnosed with type 2 diabetes every year. The sooner they start taking metformin, the better and longer it seems to work,” said the study’s lead author Jonathan B. Brown, an investigator with the Kaiser Permanente Center for Health Research in Portland, Ore.
What is type 2 diabetes?